In prostate cancer, ARPC1A is transcriptionally regulated by STAT3: It not only supplies energy to cancer cells by enhancing oxidative phosphorylation but also maintains an immunosuppressive microenvironment by inhibiting ferroptosis—creating favorable conditions for cancer progression (Zhou et al., 2025; Ji et al., 2022). Here, STAT3 is linked to cancer.